Company Overview - PMGC Holdings Inc. has rebranded its subsidiaries to align with its evolving focus as a diversified holding company [1][3] - The company now manages three wholly owned subsidiaries: Northstrive Biosciences Inc., PMGC Research Inc., and PMGC Capital LLC [3] Subsidiary Details - PMGC Research Inc. (formerly Elevai Research Inc.) focuses on advancing scientific discovery through public-private collaborations and Canadian research grants [1][5] - Northstrive Biosciences Inc. (formerly Elevai Biosciences, Inc.) is dedicated to developing innovative aesthetic medicines, with its lead asset EL-22 targeting obesity by preserving muscle during weight loss treatments [2][5] Strategic Focus - Both subsidiaries aim to drive innovation and deliver transformative solutions in their respective fields [3]
PMGC Holdings Inc. Announces Name Change of Wholly Owned Subsidiaries